scholarly article | Q13442814 |
P2093 | author name string | Xiongbin Lu | |
Xiaoming He | |||
Xiaoxiao Hu | |||
Kyle Gilstrap | |||
P2860 | cites work | Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma | Q24632791 |
Cancer statistics, 2010 | Q27860525 | ||
A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 | ||
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans | Q27860867 | ||
RNA interference | Q28131798 | ||
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs | Q28285226 | ||
Toxicity and environmental risks of nanomaterials: challenges and future needs | Q28308291 | ||
Tumor Ablation and Nanotechnology | Q28385067 | ||
Drug penetration in solid tumours | Q29614404 | ||
Expression profiling reveals off-target gene regulation by RNAi | Q29615965 | ||
Pulsed-high intensity focused ultrasound and low temperature-sensitive liposomes for enhanced targeted drug delivery and antitumor effect. | Q30493238 | ||
Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. | Q30667415 | ||
Engineering lipid vesicles of enhanced intratumoral transport capabilities: correlating liposome characteristics with penetration into human prostate tumor spheroids. | Q33224253 | ||
Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure. | Q33237308 | ||
A parallel approach for subwavelength molecular surgery using gene-specific positioned metal nanoparticles as laser light antennas | Q33270185 | ||
Strategy of topical vaccination with nanoparticles | Q33437046 | ||
Thermosensitive liposomes entrapping iron oxide nanoparticles for controllable drug release | Q33440240 | ||
Percutaneous cryoablation techniques and clinical applications | Q33517650 | ||
Cooperative nanomaterial system to sensitize, target, and treat tumors | Q33524689 | ||
Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cells | Q33539248 | ||
Radiofrequency field-induced thermal cytotoxicity in cancer cells treated with fluorescent nanoparticles | Q33610377 | ||
Nano and microparticles as controlled drug delivery devices. | Q34037126 | ||
RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo | Q34379366 | ||
Superparamagnetic Iron Oxide Nanotheranostics for Targeted Cancer Cell Imaging and pH-Dependent Intracellular Drug Release | Q34384411 | ||
The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors | Q34463656 | ||
Delivery of RNA interference | Q34561667 | ||
Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation | Q34589920 | ||
Magnetically mediated hyperthermia: current status and future directions | Q34701497 | ||
Off-target effects by siRNA can induce toxic phenotype | Q34703017 | ||
Generations of sequencing technologies | Q34875590 | ||
Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis | Q35103511 | ||
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs | Q45147309 | ||
Binding and interstitial penetration of liposomes within avascular tumor spheroids. | Q45878088 | ||
Cancer-specific transgene expression mediated by systemic injection of nanoparticles | Q45883573 | ||
Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. | Q46793159 | ||
Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size | Q47230491 | ||
Instantaneous drug delivery of magnetic/thermally sensitive nanospheres by a high-frequency magnetic field | Q47273220 | ||
Contrasting properties of gold nanoparticles for optical coherence tomography: phantom, in vivo studies and Monte Carlo simulation. | Q47394286 | ||
Exploring the uses of RNAi--gene knockdown and the Nobel Prize | Q48333410 | ||
Layer-by-layer assembled gold nanoparticles for siRNA delivery. | Q50598283 | ||
Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: swelling induced physical disruption of endosome by cold shock. | Q50659120 | ||
Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS). | Q50686054 | ||
Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals. | Q50767825 | ||
TNF-alpha-based accentuation in cryoinjury--dose, delivery, and response. | Q50958899 | ||
Toward a systems engineering approach to cancer drug delivery. | Q50968982 | ||
Iron oxide nanoparticles for sustained delivery of anticancer agents. | Q51444164 | ||
Targeting tumor microvessels using doxorubicin encapsulated in a novel thermosensitive liposome. | Q51598654 | ||
Temperature-sensitive pluronic/poly(ethylenimine) nanocapsules for thermally triggered disruption of intracellular endosomal compartment. | Q52571400 | ||
Clinical applications of magnetic nanoparticles for hyperthermia. | Q52917224 | ||
Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. | Q53589874 | ||
Basic studies of cryochemotherapy in a murine tumor system | Q57116706 | ||
Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo | Q57185352 | ||
Remote electronic control of DNA hybridization through inductive coupling to an attached metal nanocrystal antenna | Q59077081 | ||
Measurement of material extravasation in microvascular networks using fluorescence video-microscopy | Q72623570 | ||
Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice | Q72805237 | ||
Gene silencing by systemic delivery of synthetic siRNAs in adult mice | Q73166515 | ||
A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model | Q73574280 | ||
Radio-frequency ablation increases intratumoral liposomal doxorubicin accumulation in a rat breast tumor model | Q74686767 | ||
Application of nanotechnology in cancer therapy and imaging | Q80566445 | ||
Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticle-loaded anti-HER2 immunoliposomes | Q80800309 | ||
Determination of biological vector characteristics and nanoparticle dimensions for radioimmunotherapy with radioactive nanoparticles | Q81390596 | ||
Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer | Q83720010 | ||
Use of tumor necrosis factor-alpha-coated gold nanoparticles to enhance radiofrequency ablation in a translational model of renal tumors | Q84186100 | ||
Proton therapy | Q84582567 | ||
Hyperthermia classic commentary: 'Inductive heating of ferrimagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermia' by Andreas Jordan et al., International Journal of Hyperthermia, 1993;9:51-68 | Q84766359 | ||
Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug | Q39831915 | ||
The encapsulation and intracellular delivery of trehalose using a thermally responsive nanocapsule. | Q39837519 | ||
Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug | Q39923965 | ||
Tumor necrosis factor-alpha-induced accentuation in cryoinjury: mechanisms in vitro and in vivo | Q39947697 | ||
Enhancement in treatment planning for magnetic nanoparticle hyperthermia: optimization of the heat absorption pattern | Q39956376 | ||
Anticancer drugs are synergistic with freezing in induction of apoptosis in HCC cells | Q39967373 | ||
Hyperthermia adds to chemotherapy | Q40047776 | ||
Cryoinjury of MCF-7 human breast cancer cells and inhibition of post-thaw recovery using TNF-alpha | Q40053738 | ||
Nanotherapeutics for enhancing thermal therapy of cancer | Q40063990 | ||
Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide | Q40145773 | ||
Toxicogenomics of drug delivery systems: Exploiting delivery system-induced changes in target gene expression to enhance siRNA activity | Q40158066 | ||
Benefit of a combined treatment of cryotherapy and chemotherapy on tumour growth and late cryo-induced angiogenesis in a non-small-cell lung cancer model | Q40247226 | ||
Particle therapy and treatment of cancer | Q40300917 | ||
Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma | Q40365729 | ||
Effects of cryotherapy or chemotherapy on apoptosis in a non-small-cell lung cancer xenografted into SCID mice. | Q40458514 | ||
Delivery of systemic chemotherapeutic agent to tumors by using focused ultrasound: study in a murine model. | Q40465683 | ||
Secretory phospholipase A2 as a tumor-specific trigger for targeted delivery of a novel class of liposomal prodrug anticancer etherlipids | Q40492295 | ||
Addition of anticancer agents enhances freezing-induced prostate cancer cell death: implications of mitochondrial involvement | Q40533236 | ||
Pre-treatment inflammation induced by TNF-alpha augments cryosurgical injury on human prostate cancer. | Q40533244 | ||
Cryoimmunological therapy with local injection of OK-432 against advance or recurrent breast cancer | Q40545949 | ||
Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. | Q40609513 | ||
Triggered release of aqueous content from liposome-derived sol-gel nanocapsules. | Q41623899 | ||
Chemo-cryo combination therapy: an adjunctive model for the treatment of prostate cancer | Q41630602 | ||
Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme | Q42060733 | ||
Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma. | Q42801552 | ||
Preliminary evaluation of caspases-dependent apoptosis signaling pathways of free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells | Q43569874 | ||
Therapeutic effect of multimodal therapy, such as cryosurgery, locoregional immunotherapy and systemic chemotherapy against far advanced breast cancer | Q43798991 | ||
Tumor regression by targeted gene delivery to the neovasculature | Q44044889 | ||
Localized delivery to CT-26 tumors in mice using thermosensitive liposomes | Q44523993 | ||
Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation | Q44618230 | ||
Novel temperature-sensitive liposomes with prolonged circulation time | Q44812878 | ||
Phase I trial of doxorubicin-containing low temperature sensitive liposomes in spontaneous canine tumors | Q44867437 | ||
Improved cryosurgery by use of thermophysical and inflammatory adjuvants | Q35731918 | ||
Intravenous, non-viral RNAi gene therapy of brain cancer | Q35842672 | ||
The design and exogenous delivery of siRNA for post-transcriptional gene silencing. | Q35950928 | ||
Introduction: thermal ablation therapy. | Q36022031 | ||
Thermal ablation of prostate diseases: advantages and limitations | Q36022035 | ||
Combination radiofrequency thermal ablation and adjuvant IV liposomal doxorubicin increases tissue coagulation and intratumoural drug accumulation | Q36022056 | ||
Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of "heat-controlled necrosis" with heat shock protein expression | Q36245290 | ||
Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy | Q36299906 | ||
Delivery strategies for siRNA-mediated gene silencing | Q36446972 | ||
Structural and biochemical advances in mammalian RNAi | Q36574683 | ||
RNAi therapeutics: a potential new class of pharmaceutical drugs | Q36654918 | ||
Poly(ethylene oxide)-poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs | Q36811782 | ||
Biodegradable nanoparticles for cytosolic delivery of therapeutics | Q36904010 | ||
Chemotherapy-induced nausea and vomiting: which antiemetic for which therapy? | Q36917598 | ||
Polymers and nanoparticles: intelligent tools for intracellular targeting? | Q36931202 | ||
Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging | Q36995530 | ||
Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance. | Q37187003 | ||
Nanotechnology for breast cancer therapy | Q37229262 | ||
Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system | Q37307760 | ||
Treatment of cancer with cryochemotherapy | Q37352767 | ||
Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice | Q37392147 | ||
Cryotherapy for breast cancer: a feasibility study without excision | Q37398577 | ||
Local surgical, ablative, and radiation treatment of metastases | Q37443403 | ||
Nanoparticles for thermal cancer therapy | Q37565543 | ||
Adjuvant approaches to enhance cryosurgery | Q37565553 | ||
Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery | Q37835914 | ||
In vitro transcription and translation inhibition via DNA functionalized gold nanoparticles | Q38339125 | ||
The down regulation of target genes by photo activated DNA nanoscissors. | Q38342720 | ||
Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects | Q38464708 | ||
The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. | Q39615596 | ||
Noninvasive radiofrequency field destruction of pancreatic adenocarcinoma xenografts treated with targeted gold nanoparticles | Q39622805 | ||
Synthesis and characterization of thermally responsive Pluronic F127-chitosan nanocapsules for controlled release and intracellular delivery of small molecules. | Q39637577 | ||
The pharmacology of monoclonal antibodies | Q39696563 | ||
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses | Q39800142 | ||
Feasibility of chemohyperthermia with docetaxel-embedded magnetoliposomes as minimally invasive local treatment for cancer | Q39807525 | ||
P433 | issue | 4 | |
P921 | main subject | nanotechnology | Q11468 |
P304 | page(s) | 508-520 | |
P577 | publication date | 2011-03-11 | |
P1433 | published in | American Journal of Cancer Research | Q17511667 |
P1476 | title | Nanotechnology for energy-based cancer therapies | |
P478 | volume | 1 |
Q35856410 | A biomimetic hybrid nanoplatform for encapsulation and precisely controlled delivery of theranostic agents. [Corrected] |
Q34807285 | A novel implantable glaucoma valve using ferrofluid |
Q57350148 | Enhanced cancer therapy with cold-controlled drug release and photothermal warming enabled by one nanoplatform |
Q30461227 | Plasmonic nanobubbles rapidly detect and destroy drug-resistant tumors |
Q34061502 | Thermally responsive nanoparticle-encapsulated curcumin and its combination with mild hyperthermia for enhanced cancer cell destruction |
Search more.